Alexandra Maclean - Net Worth and Insider Trading

Alexandra Maclean Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Alexandra Maclean owns 1 companies in total, including Avenue Therapeutics Inc (ATXI) .

Click here to see the complete history of Alexandra Maclean’s form 4 insider trades.

Insider Ownership Summary of Alexandra Maclean

Ticker Company Transaction Date Type of Owner
ATXI Avenue Therapeutics Inc 2022-08-01 Chief Executive Officer

Alexandra Maclean Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Alexandra Maclean Ownership Network

Ownership Network List of Alexandra Maclean

No Data

Ownership Network Relation of Alexandra Maclean

Insider Network Chart

Alexandra Maclean's Compensation Overview

Company Year Salary($) Bonus($) Stock Awards($) Option Awards($) Equity Awards($) Non-Equity Incentive Plan($) All Other Compensation($) Change in Pension and Deferred Comp($) Total($)
Avenue Therapeutics Inc 2023 400,000 N/A N/A 800,000 N/A N/A 13,200 N/A 1,213,200
LIMIT LIMIT LIMIT LIMIT LIMIT LIMIT LIMIT LIMIT LIMIT LIMIT LIMIT

Alexandra Maclean Owned Company Details

What does Avenue Therapeutics Inc do?

Who are the key executives at Avenue Therapeutics Inc?

Alexandra Maclean is the Chief Executive Officer of Avenue Therapeutics Inc. Other key executives at Avenue Therapeutics Inc include 10 percent owner Fortress Biotech, Inc. , 10 percent owner Invagen Pharmaceuticals, Inc. , and Int. PEO & Int. PFO & and COO David Jin .

Avenue Therapeutics Inc (ATXI) Insider Trades Summary

Over the past 18 months, Alexandra Maclean made no insider transaction in Avenue Therapeutics Inc (ATXI). Other recent insider transactions involving Avenue Therapeutics Inc (ATXI) include a net purchase of 439 shares made by Jay D Kranzler , a net sale of 617,000 shares made by , and a net sale of 23 shares made by Neil Herskowitz .

In summary, during the past 3 months, insiders sold 0 shares of Avenue Therapeutics Inc (ATXI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 8,311 shares of Avenue Therapeutics Inc (ATXI) were sold and 500 shares were bought by its insiders, resulting in a net sale of 7,811 shares.

Avenue Therapeutics Inc (ATXI)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Avenue Therapeutics Inc Insider Transactions

No Available Data

Alexandra Maclean Mailing Address

Above is the net worth, insider trading, and ownership report for Alexandra Maclean. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Alexandra Maclean's mailing address is: New York Nc 10014.